“third-rock-ventures” Archives

in
Entry Author Date Location
Eleven Bio Buys Viventia, Rebrands as Cancer Drug Developer 09/21/16 Boston
Biotech Roundup: CRISPR’s 3rd IPO, Gender Diversity, Buyouts & More 09/16/16 National
Relay Therapeutics Garners $57,000,000 Series A Funding Round 09/15/16 Boston
New Relay Therapeutics Aims Supercomputers, $57M At Protein Motion 09/14/16 Boston
Seeking to Join Editas, Intellia, CRISPR Tx Makes Long Awaited IPO Push 09/12/16 Boston
Biotech Roundup: Scangos’s Exit, Zafgen’s Shakeup, Jounce, Relypsa & More 07/22/16 National
Fulcrum Therapeutics Garners $55,000,000 Series A Funding 07/21/16 Boston
With Celgene Deal, Jounce Lands $261M And a “Trusting Partner” 07/19/16 Boston
Ex-Epizyme CEO’s New Startup, Fulcrum, Nabs $55M For Gene Control Drugs 07/19/16 Boston
Harvard’s Springer Gets $51.5M From Pharmas, Others, For Latest Startup 06/30/16 Boston
See Boston’s Newest Innovators & Influencers this Wed. at INFLUX 06/20/16 Boston
A Few Tickets Still Remain for Influx—Register Today for June 22 06/13/16 Boston
Five Takeaways from “What’s Hot in Boston Biotech” 04/11/16 Boston
With New Execs, Sanofi Backing, ImmuneXcite Begins Clinical Push 03/30/16 Boston
Blueprint, Roche Ink Milestone Deal for Cancer Immunotherapy 03/15/16 Boston
East Coast Biotech Roundup: Celldex, Ensemble, CRISPR Battle & More 03/10/16 Boston
Pliant Therapeutics Receives $45,000,000 Series A Financing Round 02/19/16 San Francisco
CRISPR Hits Wall Street as Editas Bags $94M in IPO 02/02/16 Boston
Seeking A Fresh Start in Gene Therapy, Avalanche Merges With Annapurna 02/01/16 San Francisco
With Second Eye Drug Flop, Eleven Heads Back to Drawing Board 01/19/16 Boston
Accelerator, Gates Team Up in NY to Put $17M Into Rockefeller Startup 01/10/16 New York
East Coast Bio Roundup: NY Startups, Editas, Bonney, C4 & (Much) More 01/08/16 Boston
Former Cubist CEO Mike Bonney Joins Third Rock Ventures 01/07/16 Boston
Eight Things You Might Not Have Known Until Editas Filed Its S-1 01/04/16 Boston
Constellation Pharmaceuticals Lands $55,000,000 New Funding Round 12/10/15 Boston
With Drugs in Clinic, Constellation Nabs $55M For IPO Push 12/09/15 Boston
NinePoint, Under New Leadership, Bags $31M More For Imaging Tech 11/30/15 Boston
Idea Behind Warp Drive’s New Cancer Attack Was Hiding In Plain Sight 11/10/15 Boston
Ex-Blueprint Med CEO Resurfaces With $7.5M to Fight Genetic Blindness 11/09/15 Boston
Despite Sanofi’s Help, MyoKardia Prices IPO Below Expectations 10/29/15 San Francisco
Page 1 of 15 next page »